These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26278818)

  • 21. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo.
    Lin KH; Kuo JR; Lu WJ; Chung CL; Chou DS; Huang SY; Lee HC; Sheu JR
    Biochem Pharmacol; 2013 May; 85(10):1478-85. PubMed ID: 23473801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Qihuang Zhuyu formula alleviates coronary microthrombosis by inhibiting PI3K/Akt/αIIbβ3-mediated platelet activation.
    Ding Y; Xiang Q; Zhu P; Fan M; Tong H; Wang M; Cheng S; Yu P; Shi H; Zhang H; Chen X
    Phytomedicine; 2024 Mar; 125():155276. PubMed ID: 38295661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological properties of a specific Galpha q/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress.
    Uemura T; Kawasaki T; Taniguchi M; Moritani Y; Hayashi K; Saito T; Takasaki J; Uchida W; Miyata K
    Br J Pharmacol; 2006 May; 148(1):61-9. PubMed ID: 16520742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiplatelet and antithrombotic activity of indole-3-carbinol in vitro and in vivo.
    Park MK; Rhee YH; Lee HJ; Lee EO; Kim KH; Park MJ; Jeon BH; Shim BS; Jung CH; Choi SH; Ahn KS; Kim SH
    Phytother Res; 2008 Jan; 22(1):58-64. PubMed ID: 17724769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydrogen sulfide-releasing aspirin derivative ACS14 exerts strong antithrombotic effects in vitro and in vivo.
    Pircher J; Fochler F; Czermak T; Mannell H; Kraemer BF; Wörnle M; Sparatore A; Del Soldato P; Pohl U; Krötz F
    Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):2884-91. PubMed ID: 23023375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved antithrombotic activity and diminished bleeding side effect of a PEGylated αIIbβ3 antagonist, disintegrin.
    Hsu CC; Chuang WJ; Chung CH; Chang CH; Peng HC; Huang TF
    Thromb Res; 2016 Jul; 143():3-10. PubMed ID: 27161326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrin alphaIIbbeta3-specific synthetic human monoclonal antibodies and HCDR3 peptides that potently inhibit platelet aggregation.
    Chung J; Rader C; Popkov M; Hur YM; Kim HK; Lee YJ; Barbas CF
    FASEB J; 2004 Feb; 18(2):361-3. PubMed ID: 14688205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tangeretin regulates platelet function through inhibition of phosphoinositide 3-kinase and cyclic nucleotide signaling.
    Vaiyapuri S; Ali MS; Moraes LA; Sage T; Lewis KR; Jones CI; Gibbins JM
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2740-9. PubMed ID: 24135020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrin cytoplasmic tyrosine motif is required for outside-in alphaIIbbeta3 signalling and platelet function.
    Law DA; DeGuzman FR; Heiser P; Ministri-Madrid K; Killeen N; Phillips DR
    Nature; 1999 Oct; 401(6755):808-11. PubMed ID: 10548108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opposing Roles for the α Isoform of the Catalytic Subunit of Protein Phosphatase 1 in Inside-Out and Outside-In Integrin Signaling in Murine Platelets.
    Khatlani T; Pradhan S; Langlois K; Subramanyam D; Rumbaut RE; Vijayan KV
    Cells; 2023 Oct; 12(20):. PubMed ID: 37887268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of riboflavin and ultraviolet light treatment on platelet thrombus formation on collagen via integrin αIIbβ3 activation.
    Terada C; Mori J; Okazaki H; Satake M; Tadokoro K
    Transfusion; 2014 Jul; 54(7):1808-16. PubMed ID: 24506417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of arterial thrombus formation in two canine models: comparison of ancrod, a fibrinogen-depleting agent, the thrombin-inhibitor r-hirudin, and the glycoprotein 11b/IIIa-receptor antagonist Ro 43-8857.
    Rübsamen K; Hornberger W; Kirchengast M
    Thromb Haemost; 1995 Nov; 74(5):1353-60. PubMed ID: 8607122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New orally active non-peptide fibrinogen receptor (GpIIb-IIIa) antagonists: identification of ethyl 3-[N-[4-[4-[amino[(ethoxycarbonyl) imino]methyl]phenyl]-1,3-thiazol-2-yl]-N-[1-[(ethoxycarbonyl)methyl]pip erid -4-yl]amino]propionate (SR 121787) as a potent and long-acting antithrombotic agent.
    Badorc A; Bordes MF; de Cointet P; Savi P; Bernat A; Lalé A; Petitou M; Maffrand JP; Herbert JM
    J Med Chem; 1997 Oct; 40(21):3393-401. PubMed ID: 9341914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rumex acetosella Inhibits Platelet Function via Impaired MAPK and Phosphoinositide 3-Kinase Signaling.
    Jeon BR; Irfan M; Lee SE; Lee JH; Rhee MH
    Chin J Integr Med; 2022 Sep; 28(9):802-808. PubMed ID: 34546536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological actions of dieckol on modulation of platelet functions and thrombus formation via integrin α
    Irfan M; Kwon TH; Kwon HW; Rhee MH
    Pharmacol Res; 2022 Mar; 177():106088. PubMed ID: 35038555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curdione inhibits thrombin-induced platelet aggregation via regulating the AMP-activated protein kinase-vinculin/talin-integrin αIIbβ3 sign pathway.
    Fang H; Gao B; Zhao Y; Fang X; Bian M; Xia Q
    Phytomedicine; 2019 Aug; 61():152859. PubMed ID: 31039534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antithrombotic activity of EP224283, a neutralizable dual factor Xa inhibitor/glycoprotein IIbIIIa antagonist, exceeds that of the coadministered parent compounds.
    Hechler B; Freund M; Alame G; Leguay C; Gaertner S; Cazenave JP; Petitou M; Gachet C
    J Pharmacol Exp Ther; 2011 Aug; 338(2):412-20. PubMed ID: 21527535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3) Binder Rasa3 Regulates Phosphoinositide 3-kinase (PI3K)-dependent Integrin αIIbβ3 Outside-in Signaling.
    Battram AM; Durrant TN; Agbani EO; Heesom KJ; Paul DS; Piatt R; Poole AW; Cullen PJ; Bergmeier W; Moore SF; Hers I
    J Biol Chem; 2017 Feb; 292(5):1691-1704. PubMed ID: 27903653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myricetin as a promising inhibitor of platelet fibrinogen receptor in humans.
    Chang Y; Hsia CW; Huang WC; Jayakumar T; Hsia CH; Yen TL; Sheu JR; Hou SM
    Heliyon; 2023 Oct; 9(10):e20286. PubMed ID: 37767484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction of drug screening cell model and application to new compounds inhibiting FITC-fibrinogen binding to CHO cells expressing human alphaIIbbeta3.
    Yang J; Yao J; Chen J; Wang XN; Zhu TY; Chen LL; Chu P
    Eur J Pharmacol; 2009 Sep; 618(1-3):1-8. PubMed ID: 19619528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.